Evidence map›Paper›PMID 27217896›Full record

ArticleThe Pan African medical journal2016

An assessment of option B implementation for the prevention of mother to child transmission in Dschang, Cameroon: results from the DREAM (Drug Resource Enhancement against AIDS and Malnutrition) cohort.

Anna Maria Doro Altan, Francis Taafo, François Fopa, Ersilia Buonomo, Maria Cristina Marazzi, Karin Nielsen-Saines, Stefano Orlando, Paola Scarcella, Fausto Ciccacci, Sandro Mancinelli and 2 more

Abstract read
In one paragraph

Article in The Pan African medical journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Observational
  10. Impact of Option BAIDS patient care and STDs · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anna Maria Doro AltanDREAM programme, Community of Sant'Egidio, Rome, Italy.
Francis TaafoDREAM Center, Dschang, Cameroon.
François FopaDREAM Center, Dschang, Cameroon.
Ersilia BuonomoDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, Italy.
Maria Cristina MarazziUniversity LUMSA, Rome, Italy.
Karin Nielsen-SainesDepartment of Pediatrics, David Geffen UCLA School of Medicine, Los Angeles, California.
Stefano OrlandoDREAM programme, Community of Sant'Egidio, Rome, Italy.
Paola ScarcellaDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, Italy.
Fausto CiccacciDREAM programme, Community of Sant'Egidio, Rome, Italy.
Sandro MancinelliDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, Italy.
Massimo Magnano San LioDREAM programme, Community of Sant'Egidio, Rome, Italy.
Leonardo PalombiDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionScaling up of antiretroviral therapy (ART) to HIV+ pregnant women is crucial for the elimination of HIV infection in children. The aim of this study was to evaluate the feasibility and effectiveness of triple ART for Prevention of Mother-to Child Transmission (PMTCT) in Cameroon.

methodsHIV-positive pregnant women attending the DREAM Centre of Dschang, Cameroon for prenatal care were enrolled in a prospective cohort study, and received ART until the end of breastfeeding or indefinitely if their CD4 count was <350mm(3). Infants were evaluated for HIV infection at 1, 6 and 12 months of age.

resultsA total of 298 women were enrolled. Among them, 152 were already on established ART. Women were followed until 6 months after delivery with a retention rate of 92.6%. Eight women died. Those with a CD4 count <350 cells/mm(3) during pregnancy had the highest mortality risk (RR 2.53; 95% CL= 1.86-3.44). The HIV transmission rate was 1.2% at 12 months with an HIV free survival of 91%. In the proportional Cox regression analysis, the following factors were positively associated with infant mortality: maternal CD4< 350 cells/mm(3), no breastfeeding in the first 6 months of life, weight-for-age z score<-2.

conclusionResults confirm the feasibility and effectiveness of the implementation of Option B, with very low rates of HIV MTC transmission, and potential benefits to the health of mothers and infants with earlier initiation of ART. Breastfeeding again demonstrates to be highly beneficial for the growth and survival of HIV exposed children.

Indexed as

AdultAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveBreast FeedingCameroonCD4 Lymphocyte CountCohort StudiesFeasibility StudiesFemaleFollow-Up StudiesHIV InfectionsHumansInfantInfectious Disease Transmission, VerticalPregnancyPregnancy Complications, InfectiousAnti-HIV AgentsbreastfeedingCameroonHIVmother-to-child transmission (MTCT)Option B

Identifiers

PMID27217896
PMCPMC4862786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.